209 related articles for article (PubMed ID: 22187379)
1. Nerve growth factor gene therapy using adeno-associated viral vectors prevents cardiomyopathy in type 1 diabetic mice.
Meloni M; Descamps B; Caporali A; Zentilin L; Floris I; Giacca M; Emanueli C
Diabetes; 2012 Jan; 61(1):229-40. PubMed ID: 22187379
[TBL] [Abstract][Full Text] [Related]
2. AAV9-Mediated Cardiac CNTF Overexpression Exacerbated Adverse Cardiac Remodeling in Streptozotocin-Induced Type 1 Diabetic Models.
Zhong P; Peng J; Liu T; Ding HS
Cardiovasc Toxicol; 2022 Jan; 22(1):88-96. PubMed ID: 34674150
[TBL] [Abstract][Full Text] [Related]
3. Phosphoinositide 3-kinase (p110α) gene delivery limits diabetes-induced cardiac NADPH oxidase and cardiomyopathy in a mouse model with established diastolic dysfunction.
Prakoso D; De Blasio MJ; Qin C; Rosli S; Kiriazis H; Qian H; Du XJ; Weeks KL; Gregorevic P; McMullen JR; Ritchie RH
Clin Sci (Lond); 2017 Jun; 131(12):1345-1360. PubMed ID: 28487469
[TBL] [Abstract][Full Text] [Related]
4. Gene therapy targeting cardiac phosphoinositide 3-kinase (p110α) attenuates cardiac remodeling in type 2 diabetes.
Prakoso D; De Blasio MJ; Tate M; Kiriazis H; Donner DG; Qian H; Nash D; Deo M; Weeks KL; Parry LJ; Gregorevic P; McMullen JR; Ritchie RH
Am J Physiol Heart Circ Physiol; 2020 Apr; 318(4):H840-H852. PubMed ID: 32142359
[TBL] [Abstract][Full Text] [Related]
5. LAZ3 protects cardiac remodeling in diabetic cardiomyopathy via regulating miR-21/PPARa signaling.
Gao L; Liu Y; Guo S; Xiao L; Wu L; Wang Z; Liang C; Yao R; Zhang Y
Biochim Biophys Acta Mol Basis Dis; 2018 Oct; 1864(10):3322-3338. PubMed ID: 30031228
[TBL] [Abstract][Full Text] [Related]
6. Inhibiting microRNA-144 abates oxidative stress and reduces apoptosis in hearts of streptozotocin-induced diabetic mice.
Yu M; Liu Y; Zhang B; Shi Y; Cui L; Zhao X
Cardiovasc Pathol; 2015; 24(6):375-81. PubMed ID: 26164195
[TBL] [Abstract][Full Text] [Related]
7. Nerve growth factor rescues diabetic mice heart after ischemia/reperfusion injury via up-regulation of the TRPV1 receptor.
Zheng LR; Zhang YY; Han J; Sun ZW; Zhou SX; Zhao WT; Wang LH
J Diabetes Complications; 2015 Apr; 29(3):323-8. PubMed ID: 25650182
[TBL] [Abstract][Full Text] [Related]
8. Diazoxide preconditioning of endothelial progenitor cells from streptozotocin-induced type 1 diabetic rats improves their ability to repair diabetic cardiomyopathy.
Ali M; Mehmood A; Anjum MS; Tarrar MN; Khan SN; Riazuddin S
Mol Cell Biochem; 2015 Dec; 410(1-2):267-79. PubMed ID: 26359087
[TBL] [Abstract][Full Text] [Related]
9. CCAAT/enhancer-binding protein β overexpression alleviates myocardial remodelling by regulating angiotensin-converting enzyme-2 expression in diabetes.
Tie Y; Zhai C; Zhang Y; Qin X; Yu F; Li H; Shan M; Zhang C
J Cell Mol Med; 2018 Mar; 22(3):1475-1488. PubMed ID: 29266779
[TBL] [Abstract][Full Text] [Related]
10. Intravenous gene therapy with PIM-1 via a cardiotropic viral vector halts the progression of diabetic cardiomyopathy through promotion of prosurvival signaling.
Katare R; Caporali A; Zentilin L; Avolio E; Sala-Newby G; Oikawa A; Cesselli D; Beltrami AP; Giacca M; Emanueli C; Madeddu P
Circ Res; 2011 May; 108(10):1238-51. PubMed ID: 21474815
[TBL] [Abstract][Full Text] [Related]
11. Fibroblast growth factor-21 prevents diabetic cardiomyopathy via AMPK-mediated antioxidation and lipid-lowering effects in the heart.
Yang H; Feng A; Lin S; Yu L; Lin X; Yan X; Lu X; Zhang C
Cell Death Dis; 2018 Feb; 9(2):227. PubMed ID: 29445083
[TBL] [Abstract][Full Text] [Related]
12. MiR-21 protected against diabetic cardiomyopathy induced diastolic dysfunction by targeting gelsolin.
Dai B; Li H; Fan J; Zhao Y; Yin Z; Nie X; Wang DW; Chen C
Cardiovasc Diabetol; 2018 Sep; 17(1):123. PubMed ID: 30180843
[TBL] [Abstract][Full Text] [Related]
13. Diabetes enhances the efficacy of AAV2 vectors in the retina: therapeutic effect of AAV2 encoding vasoinhibin and soluble VEGF receptor 1.
Díaz-Lezama N; Wu Z; Adán-Castro E; Arnold E; Vázquez-Membrillo M; Arredondo-Zamarripa D; Ledesma-Colunga MG; Moreno-Carranza B; Martinez de la Escalera G; Colosi P; Clapp C
Lab Invest; 2016 Mar; 96(3):283-95. PubMed ID: 26568297
[TBL] [Abstract][Full Text] [Related]
14. Gene therapy approaches for obesity-induced adipose neuropathy: Device-targeted AAV-mediated neurotrophic factor delivery to adipocytes in subcutaneous adipose.
Blaszkiewicz M; Tao T; Mensah-Arhin K; Willows JW; Bates R; Huang W; Cao L; Smith RL; Townsend KL
Mol Ther; 2024 May; 32(5):1407-1424. PubMed ID: 38429927
[TBL] [Abstract][Full Text] [Related]
15. Nerve growth factor gene therapy improves bone marrow sensory innervation and nociceptor-mediated stem cell release in a mouse model of type 1 diabetes with limb ischaemia.
Dang Z; Avolio E; Albertario A; Sala-Newby GB; Thomas AC; Wang N; Emanueli C; Madeddu P
Diabetologia; 2019 Jul; 62(7):1297-1311. PubMed ID: 31016359
[TBL] [Abstract][Full Text] [Related]
16. Protection by dimethyl fumarate against diabetic cardiomyopathy in type 1 diabetic mice likely via activation of nuclear factor erythroid-2 related factor 2.
Hu X; Rajesh M; Zhang J; Zhou S; Wang S; Sun J; Tan Y; Zheng Y; Cai L
Toxicol Lett; 2018 May; 287():131-141. PubMed ID: 29408448
[TBL] [Abstract][Full Text] [Related]
17. Cardioprotective Effect of Decorin in Type 2 Diabetes.
Chen F; Lai J; Zhu Y; He M; Hou H; Wang J; Chen C; Wang DW; Tang J
Front Endocrinol (Lausanne); 2020; 11():479258. PubMed ID: 33365011
[TBL] [Abstract][Full Text] [Related]
18. Effect of heart ischemia and administration route on biodistribution and transduction efficiency of AAV9 vectors.
García-Olloqui P; Rodriguez-Madoz JR; Di Scala M; Abizanda G; Vales Á; Olagüe C; Iglesias-García O; Larequi E; Aguado-Alvaro LP; Ruiz-Villalba A; Prosper F; Gonzalez-Aseguinolaza G; Pelacho B
J Tissue Eng Regen Med; 2020 Jan; 14(1):123-134. PubMed ID: 31677236
[TBL] [Abstract][Full Text] [Related]
19. Nerve growth factor supplementation reverses the impairment, induced by Type 1 diabetes, of hindlimb post-ischaemic recovery in mice.
Salis MB; Graiani G; Desortes E; Caldwell RB; Madeddu P; Emanueli C
Diabetologia; 2004 Jun; 47(6):1055-63. PubMed ID: 15184980
[TBL] [Abstract][Full Text] [Related]
20. Transduction of rat pancreatic islets with pseudotyped adeno-associated virus vectors.
Craig AT; Gavrilova O; Dwyer NK; Jou W; Pack S; Liu E; Pechhold K; Schmidt M; McAlister VJ; Chiorini JA; Blanchette-Mackie EJ; Harlan DM; Owens RA
Virol J; 2009 May; 6():61. PubMed ID: 19450275
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
